How to Buy Mirum Pharmaceuticals Stock
Mirum Pharmaceuticals Inc
Mirum Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.
Mirum Pharmaceuticals stock last closed at $52.24, up 0.42% from the previous day, and has increased 35.69% in one year. It has overperformed other stocks in the Biotechnology industry by 0.97 percentage points. Mirum Pharmaceuticals stock is currently +41.73% from its 52-week low of $36.86, and -4.54% from its 52-week high of $54.73.
At the moment, there are 49.53M shares of MIRM outstanding. The market value of MIRM is $2.59B. In the last 24 hours, 314,000 MIRM shares were traded.
How to Buy Mirum Pharmaceuticals Stock
Not sure how to invest in Mirum Pharmaceuticals stock? Here's how.
- Figure out where to buy Mirum Pharmaceuticals stock: You need to choose an online brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you determine where to buy Mirum Pharmaceuticals stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Put funds into your brokerage account: Pick your payment method and add your information.
- Evaluate Mirum Pharmaceuticals stock: The Mirum Pharmaceuticals ticker symbol is MIRM. Is Mirum Pharmaceuticals stock a good investment? Should you buy shares of MIRM? How do MIRM's underlying business fundamentals look? Do top analysts think Mirum Pharmaceuticals is a good buy? Why has MIRM's stock price moved recently? (Hint: Our stock market analysis website can help you decide if MIRM is a good stock to buy).
- Execute your MIRM trade: Decide if you will purchase MIRM shares at the current market price or use a limit order to buy MIRM stock at a specific price.
- Monitor your MIRM investment: Create a watchlist to important updates regarding your position in Mirum Pharmaceuticals shares.
Step 1: Figure out where to buy Mirum Pharmaceuticals stock
You will need an online brokerage account in order to access the NASDAQ market and buy MIRM stock.
Our preferred brokerage: eToro
We believe that eToro is the best stock brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world markets: From Tech to Utilities, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've selected your brokerage, you need to fill out some personal info so you are able to invest in MIRM today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to start your new trading account.
- Submit your details by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have created your account on the greatest app to buy stocks, your next step is to transfer the money for your investment:
Watch this video walkthrough for more details depositing funds into your new brokerage account.
Step 4: Evaluate Mirum Pharmaceuticals stock
Once you have decided on the best place to buy Mirum Pharmaceuticals stock, it's very important to evaluate their stock before you buy, so you actually comprehend the risk as well as the opportunity.
Mirum Pharmaceuticals stock quick numbers
Mirum Pharmaceuticals Fundamentals
WallStreetZen was designed to help everyday investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on MIRM's stock page.
How is MIRM stock valued?
Investors use many financial metrics, analyses, models, and charts to gauge MIRM's fair value.
Using relative valuations metrics:
- MIRM may be overvalued based on its P/B ratio of 11.09x, relative to Biotechnology industry P/B ratio of 4.38x
You can access additional valuation analysis on MIRM's stock here.
MIRM Financials at a glance
Positive Financial Indicators:
- There are more short-term assets than long-term liabilities on the MIRM balance sheet.
- There are more short-term assets than short-term liabilities on the MIRM balance sheet.
- MIRM profit margin has gone up from -70.8% to -20.4% in the past year.
- MIRM has $278.10M in cash and short term investments. This is enough to cover its annual cash burn of $7.87M.
- MIRM has cash burn of 7869000. It has enough cash and short-term investments to cover this for at least one year.
Negative Financial Indicators:
- Total MIRM debt is higher than 5 years ago, relative to shareholder equity.
- MIRM has a relatively high debt to equity ratio of 1.96.
Is it a good time to buy Mirum Pharmaceuticals stock, according to Wall Street analysts?
Out of 5 sell side analysts who research MIRM, the consensus analyst rating on MIRM is a Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are projecting on the Mirum Pharmaceuticals stock forecast page.
MIRM Technicals
MIRM Growth Metrics
Last year, MIRM revenue was $379.25M. During the past 3 year, MIRM's revenue has increased by 221.32% per year. This was faster than the Biotechnology industry average of 44.97%.
You can analyze MIRM's earnings and revenue performance here.
Are MIRM insiders buying or selling the stock?
In the last 12 months, executives and large shareholders at MIRM have sold more shares than they have bought.
Jolanda Howe, SVP GLOBAL CONTROLLER of MIRM, was the latest MIRM insider to sell. They sold $23,411.16 worth of MIRM stock on Jul 3, 2025.
Learn more about who owns MIRM shares here.
Can I get consistent income from MIRM stock?
No, Mirum Pharmaceuticals doesn't provide an income stream by paying out dividends.
MIRM Social Trading Data
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your MIRM trade
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are usually sufficient. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a given price limit, use a limit order.
Hit the Open button and your broker will execute your order.
If you need more info about investing in stocks on eToro, watch the how to video below:
Step 6: Monitor your MIRM investment
Now that you own some shares in MIRM, you'll want to stay up-to-date on your new investment.
Start a watchlist to track your MIRM stock.
MIRM Feed
How to Buy Stock in Mirum Pharmaceuticals
To summarize, here are the 6 steps you need to take to buy Mirum Pharmaceuticals stock right now:
- Figure out where to buy Mirum Pharmaceuticals stock
- Sign up for a brokerage account
- Put funds into your brokerage account
- Evaluate Mirum Pharmaceuticals stock
- Execute your MIRM trade
- Monitor your MIRM investment
If you need a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get notifications regarding your investment in Mirum Pharmaceuticals, get started below.
More Content You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.